The cases reach a total of 40 according to the experts of the pharmacovigilance committee.
Of these, six have been recorded after the AstraZeneca vaccine and one after that of Johnsonn & Johnson.
The remaining 33 cases concern mRNA vaccines, ie those of Pfizer and Moderna.
According to information, all 40 incidents have gone well.